ATLASInvesco Pharmaceuticals ETF (PJP): outlook, holdings and fees
Invesco Pharmaceuticals ETF (PJP) is an exchange-traded fund and is managed by Invesco. The expense ratio is 0.57% and the yield is 0.95%. The ten largest holdings are 50% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on PJP
| Last price | $129.55 (-0.8%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 54% |
| Likely 1-month range (50%) | $126.03 – $134.34 |
| Normal 1-day range (±1σ) | ±1.1% |
| Distribution yield | 0.95% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
PJP fund facts
| Issuer | Invesco |
|---|---|
| Theme | Healthcare |
| Assets under management | $551M |
| Expense ratio | 0.57% |
| Number of holdings | 28 |
| Portfolio turnover | 38% |
| Inception | Jun 23, 2005 |
| Exchange | NYSE |
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
PJP top holdings
| Holding | Sector | Weight |
|---|---|---|
| AbbVie Inc ABBV | Healthcare | 5.64% |
| Gilead Sciences Inc GILD | Healthcare | 5.56% |
| Pfizer Inc PFE | Healthcare | 5.36% |
| Johnson & Johnson JNJ | Healthcare | 5.51% |
| Eli Lilly and Company LLY | Healthcare | 5.29% |
| Amgen Inc AMGN | Healthcare | 5.16% |
| Merck & Company Inc MRK | Healthcare | 5.51% |
| Abbott Laboratories ABT | Healthcare | 4.96% |
| Amneal Pharmaceuticals, Inc. Class A Common Stock AMRX | Healthcare | 3.53% |
| Ligand Pharmaceuticals Incorporated LGND | Healthcare | 3.36% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
PJP sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 100.0%.
PJP returns and risk
| Year to date | +19.5% |
|---|---|
| 1 year | +33.1% |
| 3 years (annualised) | +21.0% |
| 5 years (annualised) | +11.2% |
| 10 years (annualised) | +8.7% |
| Volatility (3 years) | 14.0% |
| Sharpe ratio (3 years) | 1.09 |
Past returns do not guarantee future results.
PJP: frequently asked questions
What does PJP invest in?
Invesco Pharmaceuticals ETF invests in a portfolio of securities. Its largest holdings are AbbVie Inc (5.6%), Gilead Sciences Inc (5.6%), Pfizer Inc (5.4%), Johnson & Johnson (5.5%), Eli Lilly and Company (5.3%).
What is the PJP expense ratio?
0.57% a year: about $57.00 for every $10,000 invested.
What is the PJP dividend yield?
0.95%. ATLAS does not hold the exact distribution dates for ETFs.
Will PJP go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 54%, with a likely range (50%) of $126.03 to $134.34 from $129.55 today. It is a probability, not a prediction.
How has PJP performed?
Year to date +19.5%, one year +33.1%, three years +21.0% a year, five years +11.2% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- State Street Health Care Select Sector SPDR ETF (XLV)
- Vanguard Health Care ETF (VHT)
- iShares Global Healthcare ETF (IXJ)
- iShares U.S. Healthcare ETF (IYH)
- iShares U.S. Medical Devices ETF (IHI)
- Fidelity MSCI Health Care Index ETF (FHLC)
- iShares U.S. Pharmaceuticals ETF (IHE)
- First Trust Health Care AlphaDEX Fund (FXH)
Educational information, not investment advice. Disclaimer